182 related articles for article (PubMed ID: 5384462)
1. Effect of combined therapy with cytosine arabinoside (NSC-63878) and l,3-bis-(2-chloroethyl)-1-nitrosourea (NSC-409962) on sarcoma 180 and L1210 in vivo.
Mizuno NS; Humphrey EW
Cancer Chemother Rep; 1969 Sep; 53(4):215-21. PubMed ID: 5384462
[No Abstract] [Full Text] [Related]
2. Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle.
Bray DA; DeVita VT; Adamson RH; Oliverio VT
Cancer Chemother Rep; 1971 Jun; 55(3):215-20. PubMed ID: 5115843
[No Abstract] [Full Text] [Related]
3. Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
Kinne DW; Humphrey EW
Cancer Chemother Rep; 1972 Feb; 56(1):53-9. PubMed ID: 5030809
[No Abstract] [Full Text] [Related]
4. 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.
van Eden EB; Falkson HC; Falkson G
Cancer Chemother Rep; 1970 Oct; 54(5):347-59. PubMed ID: 5514624
[No Abstract] [Full Text] [Related]
5. Separate and sequential chemotherapy of mouse leukemia L1210 with 1-beta-D-arabinofuranosylcytosine hydrochloride and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Tyrer DD; Kline I; Venditti JM; Goldin A
Cancer Res; 1967 May; 27(5):873-9. PubMed ID: 6025252
[No Abstract] [Full Text] [Related]
6. 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and methotrexate (NSC-740) as combination therapy for advanced mouse leukemia L1210.
Venditti JM; Kline I; Tyrer DD; Goldin A
Cancer Chemother Rep; 1965 Oct; 48():35-9. PubMed ID: 5834736
[No Abstract] [Full Text] [Related]
7. The effect of chemotherapy on the growth characteristics and cellular kinetics of leukemia L1210.
Young RC; DeVita VT
Cancer Res; 1970 Jun; 30(6):1789-94. PubMed ID: 5457940
[No Abstract] [Full Text] [Related]
8. Criteria associated with destruction of leukemia and solid tumor cells in animals.
Skipper HE
Cancer Res; 1967 Dec; 27(12):2636-45. PubMed ID: 6082300
[No Abstract] [Full Text] [Related]
9. Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
Kline I; Woodman RJ; Gang M; Cysyk RL; Venditti JM
Cancer Chemother Rep; 1973; 57(3):291-8. PubMed ID: 4751255
[No Abstract] [Full Text] [Related]
10. Influence of mitotic cycle inhibitors on the antileukemic activity of cytosine arabinoside (NSC-63878) in mice bearing leukemia L1210.
Vadlamudi S; Goldin A
Cancer Chemother Rep; 1971 Dec; 55(5):547-55. PubMed ID: 5159846
[No Abstract] [Full Text] [Related]
11. Effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and related compounds upon the synthesis of DNA by cell-free systems.
Wheeler GP; Bowdon BJ
Cancer Res; 1968 Jan; 28(1):52-9. PubMed ID: 5635372
[No Abstract] [Full Text] [Related]
12. Comparative effects of the antitumor agents 5-(Dimethyltriazeno)-imidazole-4-carboxamide and 1,3-bis(2-chloroethyl)-1-nitrosourea on cell cycle of L1210 leukemia cells in vivo.
Shirakawa S; Frei E
Cancer Res; 1970 Aug; 30(8):2173-90. PubMed ID: 5459764
[No Abstract] [Full Text] [Related]
13. Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by vitamin A and caffeine.
Cohen MH
J Natl Cancer Inst; 1972 Apr; 48(4):927-32. PubMed ID: 5023690
[No Abstract] [Full Text] [Related]
14. Nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037; CCNU)--clinical brochure.
Carter SK; Newman JW
Cancer Chemother Rep 3; 1968 Dec; 1(1):115-51. PubMed ID: 4917773
[No Abstract] [Full Text] [Related]
15. Effect of treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or cyclophosphamide on spleen colony-forming units and survival time of leukemic mice.
Vadlamudi S; Waravdekar VS; Choudry JN; Goldin A
Cancer Res; 1968 Jul; 28(7):1242-9. PubMed ID: 5665982
[No Abstract] [Full Text] [Related]
16. Chemotherapy and the life cycle of leukaemic cells. A comparison between the growth characteristics of human acute leukaemia and the murine leukaemia L 1210.
Benckhuijsen C
Folia Med Neerl; 1969 Dec; 12(2):74-84. PubMed ID: 4894168
[No Abstract] [Full Text] [Related]
17. Enhanced antitumor effect of cytosine arabinoside given in a schedule dictated by kinetic studies in vivo.
Young RC; Goldberg D; Schein PS
Biochem Pharmacol; 1973 Jan; 22(2):277-80. PubMed ID: 4763256
[No Abstract] [Full Text] [Related]
18. Effect of different doses of methotrexate (NSC-740), cytosine arabinoside (NSC-63878), and cyclophosphamide (NSC-26271) on drug resistance in mice with L1210 leukemia.
Schmid FA; Hutchison DJ
Cancer Chemother Rep; 1972 Aug; 56(4):473-81. PubMed ID: 5081590
[No Abstract] [Full Text] [Related]
19. Effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and cyclophosphamide (NSC-26271) on nicotinamide adenine dinucleotide glycohydrolase in normal and leukemic mouse tissues.
Tsukagoshi S; Kao MH; Goldin A
Cancer Chemother Rep; 1968 Sep; 52(5):569-78. PubMed ID: 5743704
[No Abstract] [Full Text] [Related]
20. Some determinants of the therapeutic efficacy of actinomycin D (NSC-3053), adriamycin (NSC-123127), and daunorubicin (NSC-83142).
Schwartz HS
Cancer Chemother Rep; 1974; 58(1):55-62. PubMed ID: 4521481
[No Abstract] [Full Text] [Related]
[Next] [New Search]
